References
- M. Nath, K. Bhattacharjee, and Y. Choudhury, Pleiotropic effects of anti-diabetic drugs: A comprehensive review, Eur. J. Pharmacol. 884 (2020), pp. 173349. doi:https://doi.org/10.1016/j.ejphar.2020.173349.
- P. Poornima, J.D. Kumar, Q. Zhao, M. Blunder, and T. Efferth, Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature, Pharmacol. Res. 111 (2016), pp. 290–302. doi:https://doi.org/10.1016/j.phrs.2016.06.018.
- Y. Peng, M. Ao, B. Dong, Y. Jiang, L. Yu, Z. Chen, C. Hu, and R. Xu, Anti-inflammatory effects of curcumin in the inflammatory diseases: Status, limitations and countermeasures, Drug. Des. Devel. Ther. 15 (2021), pp. 4503–4525. doi:https://doi.org/10.2147/DDDT.S327378.
- T. Kenakin, Biased receptor signaling in drug discovery, Pharmacol. Rev. 71 (2019), pp. 267–315. doi:https://doi.org/10.1124/pr.118.016790.
- S.D.M. Brown and H.V. Lad, The dark genome and pleiotropy: Challenges for precision medicine, Mamm. Genome 30 (2019), pp. 212–216. doi:https://doi.org/10.1007/s00335-019-09813-4.
- A.L. Alessandri, L.P. Sousa, C.D. Lucas, A.G. Rossi, V. Pinho, and M.M. Teixeira, Resolution of inflammation: Mechanisms and opportunity for drug development, Pharmacol. Ther. 139 (2013), pp. 189–212. doi:https://doi.org/10.1016/j.pharmthera.2013.04.006.
- A.F. Rowley, The evolution of inflammatory mediators, Med. Inflam. 5 (1996), pp. 3–13. doi:https://doi.org/10.1155/S0962935196000014.
- J. Rankin, Biological mediators of acute inflammation, AACN Clin. 15 (2004), pp. 3–17. doi:https://doi.org/10.1097/00044067-200401000-00002.
- D. MacGlashan, Histamine: A mediator of inflammation, J. Allergy Clin. Immunol. 112 (2003), pp. S53–59. doi:https://doi.org/10.1016/S0091-6749(03)01877-3.
- M. Del Grossi Moura, L.L. Cruz Lopes, M.T. Silva, S. Barberato-Filho, R.H.L. Motta, and C.C. Bergamaschi, Use of steroid and nonsteroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review protocol, Medicine (Baltimore) 97 (2018), pp. e12658. doi:https://doi.org/10.1097/MD.0000000000012658.
- J.B. Dahl, R.V. Nielsen, J. Wetterslev, L. Nikolajsen, K. Hamunen, V.K. Kontinen, M.S. Hansen, J.J. Kjer, and O. Mathiesen, and Scandinavian Postoperative Pain Alliance (ScaPAlli), Post-operative analgesic effects of paracetamol, NSAIDs, glucocorticoids, gabapentinoids and their combinations: A topical review, Acta Anaesthesiol. Scand. 58 (2014), pp. 1165–1181. doi:https://doi.org/10.1111/aas.12382.
- A. Sinniah, S. Yazid, and R.J. Flower, From NSAIDs to glucocorticoids and beyond, Cells 10 (2021), pp. 3524–3538. doi:https://doi.org/10.3390/cells10123524.
- X. Leval, F. Julémont, J. Delarge, B. Pirotte, and J.M. Dogné, New trends in dual 5-LOX/COX inhibition, Curr. Med. Chem. 9 (2002), pp. 941–962. doi:https://doi.org/10.2174/0929867024606713.
- H. Altman, L. Luciardi, J. Muntaner, and R.N. Herrera, Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs, Ann. Rheum. Dis. 62 (2003), pp. 501–509. doi:https://doi.org/10.1136/ard.62.6.501.
- R. Kodela, M. Chattopadhyay, and K. Kashfi, NOSH-aspirin: A novel nitric oxide-hydrogen sulfide-releasing hybrid: A new class of anti-inflammatory pharmaceuticals, ACS Med. Chem. Lett. 3 (2012), pp. 257–262. doi:https://doi.org/10.1021/ml300002m.
- R. Kodela, M. Chattopadhyay, C.A. Velázquez-Martínez, and K. Kashfi, NOSH-aspirin(NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications, Biochem. Pharmacol. 98 (2015), pp. 564–572. doi:https://doi.org/10.1016/j.bcp.2015.09.014.
- P. Jaismy Jacob, S.L. Manjua, K.R. Ethiraja, and G. Elias, Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach, Eur. J. Pharm. Sci. 121 (2018), pp. 356–381. doi:https://doi.org/10.1016/j.ejps.2018.06.003.
- S.D. Zanatta, D.T. Manallack, B. Jarrott, and S.J. Williams, Synthesis and evaluation of dithiolethiones as novel cyclooxygenase inhibitors, Bioorg. Med. Chem. Lett. 19 (2009), pp. 459–461. doi:https://doi.org/10.1016/j.bmcl.2008.11.045.
- M. Scholz, H.K. Ulbrich, O. Soehnlein, L. Lindbom, A. Mattern, and G. Dannhardt, Diaryl-dithiolanesand-isothiazoles: COX-1/COX-2 and 5-LOX-inhibitory, OH scavenging and anti-adhesive activities, Bioorg. Med. Chem. 17 (2009), pp. 558–568. doi:https://doi.org/10.1016/j.bmc.2008.11.074.
- P.-C. Kuo, D.A. Brown, B.A. Scofield, H.C. Paraiso, P.-Y. Wang, I.-C. Yu, and J.-H. Yen, Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis, Brain Behav. Immun. 70 (2018), pp. 76–87. doi:https://doi.org/10.1016/j.bbi.2018.03.010.
- C. Zhang, L. Xie, F. Guan, and Y. Cui, 3H-1,2-Dithiole-3-thione protects PC12 cells against amyloid beta 1–42 (Aβ1–42) induced apoptosis via activation of the ERK1/2 pathway, Life Sci. 213 (2018), pp. 74–81. doi:https://doi.org/10.1016/j.lfs.2018.10.025.
- Y.B. Cui, S.S. Ma, C.Y. Zhang, D.P. Li, B. Yang, P.J. Lv, Q. Xing, T. Huang, G.L. Yang, W. Cao, and F.X. Guan, Pharmacological activation of the Nrf2 pathway by 3H-1, 2-dithiole-3-thione is neuroprotective in a mouse model of Alzheimer disease, Behav. Brain Res. 336 (2018), pp. 219–226. doi:https://doi.org/10.1016/j.bbr.2017.09.011.
- P.-C. Kuo, D.A. Brown, B.A. Scofield, I.-C. Yu, F.-L. Chang, P.-Y. Wang, and J.-H. Yen, 3H-1,2-Dithiole-3-thione as a novel therapeutic agent for the treatment of experimental autoimmune encephalomyelitis, Brain Behav. Immun. 57 (2016), pp. 173–186. doi:https://doi.org/10.1016/j.bbi.2016.03.015.
- V. Kartsev, S.S. Kh, A. Geronikaki, S.M. Medvedeva, I.V. Ledenyova, M. Yu, A.P. Krysin, A. Ciric, J. Glamoclija, and M. Sokovic, Appendix A. dithioloquinolinethiones as new potential multitargeted antibacterial and antifungal agents: Synthesis, biological evaluation and molecular docking studies, Eur. J. Med. Chem. 175 (2019), pp. 201–214. doi:https://doi.org/10.1016/j.ejmech.2019.04.046.
- V.B. Sulimov, I.V. Gribkova, M.P. Kochugaeva, E.V. Katkova, A.V. Sulimov, D.C. Kutov, K.S. Shikhaliev, S.M. Medvedeva, M. Yu, E.I.S. Krysin, and F.I. Ataullakhanov, Application of molecular modeling to development of new factor Xa inhibitors, BioMed Res. Int. 2015 (2015), pp. 120802. doi:https://doi.org/10.1155/2015/120802.
- P. Szymański, M. Markowicz, and E. Mikiciuk-Olasik, Adaptation of high-throughput screening in drug discovery-toxicological screening tests, Int. J. Mol. Sci. 13 (2012), pp. 427–452. doi:https://doi.org/10.3390/ijms13010427.
- J.-P. Doucet and A. Panaye, Three Dimensional QSAR: Applications in Pharmacology and Toxicology, Taylor & Francis, Boca Raton, 2019.
- P. Kumar, R. Kaalia, A. Srinivasan, and I. Ghosh, Multiple target-based pharmacophore design from active site structures, SAR QSAR Environ. Res. 29 (2018), pp. 1–19. doi:https://doi.org/10.1080/1062936X.2017.1401555.
- C. Wang, P. Xu, L. Zhang, J. Huang, K. Zhu, and C. Luo, Current strategies and applications for precision drug design, Front. Pharmacol. 9 (2018), pp. 787. doi:https://doi.org/10.3389/fphar.2018.00787.
- E.N. Muratov, J. Bajorath, R.P. Sheridan, I. Tetko, D. Filimonov, V. Poroikov, T. Oprea, I.I. Baskin, A. Varnek, A. Roitberg, O. Isayev, S. Curtalolo, D. Fourches, Y. Cohen, A. Aspuru-Guzik, D.A. Winkler, D. Agrafiotis, A. Cherkasov, and A. Tropsha, QSAR without borders, Chem. Soc. Rev. 49 (2020), pp. 3525–3564. doi:https://doi.org/10.1039/d0cs00098a.
- N. Adhikari, S. Banerjee, S.K. Baidya, B. Ghosh, and T. Jha, Robust classification-based molecular modelling of diverse chemical entities as potential SARS-CoV-2 3CLpro inhibitors: Theoretical justification in light of experimental evidences, SAR QSAR Environ. Res. 32 (2021), pp. 473–493. doi:https://doi.org/10.1080/1062936X.2021.1914721.
- J.P. Doucet, E. Papa, A. Doucet-Panaye, and J. Devillers, QSAR models for predicting the toxicity of piperidine derivatives against Aedes aegypti, SAR QSAR Environ. Res. 28 (2017), pp. 451–470. doi:https://doi.org/10.1080/1062936X.2017.1328855.
- C. Ma, B. Hu, L. Zhang, Y. Zhao, M. Wang, J. Wang, and M. Cheng, Computational investigation of the antagonism effect towards GluN2B-Containing NMDA receptor: Combined ligand-based and target-based approach, J. Mol. Graph. Model. 86 (2019), pp. 95–105. doi:https://doi.org/10.1016/j.jmgm.2018.10.009.
- A.A. Lagunin, R.K. Goel, D.Y. Gawande, P. Pahwa, T.A. Gloriozova, A.V. Dmitriev, S.M. Ivanov, A.V. Rudik, V.I. Konova, P.V. Pogodin, D.S. Druzhilovskiy, and V.V. Poroikov, Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: A critical review, Nat. Prod. Rep. 31 (2014), pp. 1585–1611. doi:https://doi.org/10.1039/C4NP00068D.
- Y.V. Burov, V.V. Poroikov, and L.V. Korolchenko, National system for registration and biological testing of chemical compounds: Facilities for new drugs search, Bull. Natl. Centr. Biol. Act. Compnds. (Rus.) 1 (1990), pp. 4–25.
- D.A. Filimonov, V.V. Poroikov, E.I. Karaicheva, R.K. Kazaryan, A.P. Boudunova, E.M. Mikhailovskiy, A.V. Rudnitskih, L.V. Goncharenko, and Y.V. Burov, Computer-aided prediction of biological activity spectra of chemical substances on the basis of their structural formulae: Computer system PASS, Experim. Clin. Pharmacol. (Rus) 58 (1995), pp. 56–62.
- V.V. Poroikov, D.A. Filimonov, T.A. Gloriozova, A.A. Lagunin, D.S. Druzhilovskiy, A.V. Rudik, L.A. Stolbov, A.V. Dmitriev, O.A. Tarasova, S.M. Ivanov, and P.V. Pogodin, Computer-aided prediction of biological activity spectra for organic compounds: The possibilities and limitations, Russ. Chem. Bull. 68 (2019), pp. 2143–2154. doi:https://doi.org/10.1007/s11172-019-2683-0.
- CDDI database [https://www.cortellis.com/drugdiscovery/], accessed March 20th 2022.
- JChem. similarity search. [https://docs.chemaxon.com/display/docs/similarity-search.md], accessed March 20th 2022.
- Y.C. Martin, J.L. Kofron, and L.M. Traphagen, Do structurally similar molecules have similar biological activity?, J. Med. Chem. 45 (2002), pp. 4350–4358. doi:https://doi.org/10.1021/jm020155c.
- A. Lagunin, A. Stepanchikova, D. Filimonov, and V. Poroikov, PASS: Prediction of activity spectra for biologically active substances, Bioinformatics 16 (2000), pp. 747–748. doi:https://doi.org/10.1093/bioinformatics/16.8.747.
- PASS Online [http://www.way2drug.com/passonline], accessed March 20th 2022.
- K.A. Murtazalieva, D.S. Druzhilovskiy, R.K. Goel, G.N. Sastry, and V.V. Poroikov, How good are publicly available web services that predict bioactivity profiles for drug repurposing?, SAR QSAR Environ. Res. 28 (2017), pp. 843–862. doi:https://doi.org/10.1080/1062936X.2017.1399448.
- A. Geronikaki, V. Poroikov, D. Hadjipavlou-Litina, D. Filimonov, A. Lagunin, and R. Mgonzo, Computer aided predicting the biological activity spectra and experimental testing of new thiazole derivatives, Quant. Struct.-Activ. Relat. 18 (1999), pp. 16–25. doi:https://doi.org/10.1002/(SICI)1521-3838(199901)18:1<16::AID-QSAR16>3.0.CO;2-O.
- D.A. Filimonov, A.A. Lagunin, T.A. Gloriozova, A.V. Rudik, D.S. Druzhilovskiy, P.V. Pogodin, and V.V. Poroikov, Prediction of the biological activity spectra of organic compounds using the PASS online web resource, Chem. Heterocycl. Compnds. 50 (2014), pp. 444–457. doi:https://doi.org/10.1007/s10593-014-1496-1.
- С. Reddelin and A. Thurm, Über das angebliche Aceton-anil, Ber 65 (1932), pp. 1511–1521.
- Y.A. Ivanov, N.L. Zaichenko, S.V. Rykov, O. Ya, A.A.D. Grinberg, S.D. Pirozhkov, É.G. Rozantsev, I.E. Pokrovskaya, and A.B. Shapiro, The synthesis of hydroxy, acyloxy, oxo, N-oxide oxo, and morpholino derivatives of hydrogenated quinolines and study of their radical analogs by ESR, Russ. Chem. Bull. 28 (1979), pp. 1661–1668. doi:https://doi.org/10.1007/BF00950990.
- S.M. Medvedeva, K.S. Shikhaliev, and Z.V. Shmyreva, Some transformations of 6-oxy-2,2,4-trimethyl-1,2-dihydroquinoline, Vestnik VGU: Problemy Khimii i Biologii 1 (2002), pp. 38–40.
- E.V. Leshheva, S.M. Medvedeva, and K.S. Shihaliev, Synthesis of 4,4,6-trimethyl-8-R-4H-pyrrolo[3,2,1-ij] quinoline-1,2-diones, J. Org. Pharm. Chem. 2 (2014), pp. 15–20. doi:https://doi.org/10.24959/ophcj.14.798.
- S.M. Medvedeva, M.E. Plaksina, and S.S. Kh, The synthesis of 6-R-2,2,4-trimethyl-1,2-dihydroquinoline- and 6-R-4-R’-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline-8-carboxylic acids – The structural analogues of helquinoline, J. Org. Pharm. Chem. 13 (2015), pp. 21–25. doi:https://doi.org/10.24959/ophcj.15.847.
- J.P. Brown, Reactions of 2,2-dialkyl-1,2-dihydroquinolines. Part IV. 4,5-Dihydro-4,4-dimethyl-1H-1,2-dithiolo[3,4-c]quinoline-1-thiones, J. Chem. Soc. C (1968), pp. 1074–1075. doi:https://doi.org/10.1039/j39680001074.
- K.S. Shihaliev, V.V. Pigarev, Z.V. Shmyreva, S.M. Medvedeva, and G.I. Ermolova, Nitrovanie 4,5-digidro-4,4-dimetil-5H-2,3-ditiolo[5,4-c]hinolin-1-tiona i ego proizvodnyh, Izvestiya Vysshih Uchebnyh Zavedenij. Himiya I Himicheskaya Tekhnologiya 41 (1998), pp. 48–51.
- S.S. Kh, V.S. Zh, and L.P. Zalukaev, Acylation of 4,5-digidro-4,4-dimetil-5H-2,3-ditiolo[5,4-c]quihinolin-1-thion, Zhurnal organicheskoj himii 24 (1988), pp. 232–233.
- S.S. Kh, V.V. Pigarev, A.S. Solov’ev, and G.V. Shatalov, Sintez N-(2-getarilacetil)-8-R-4,5-digidro-4,4-dimetil-2,3-ditiolo[5,4-c]hinolin-1-tionov, Izvestiya vuzov, Himiya I Himicheskaya Tekhnologiya 43 (2000), pp. 93–94.
- S.S. Kh, S.M. Medvedeva, V.V. Pigarev, A.S. Solov’ev, and G.V. Shatalov, Novye geterociklicheskie soedineniya na osnove 8-R-4,4-dimetil-2,3-ditiolo [5,4-c] quinoline-1-tionov, Russ. J. Gen. Chem. 70 (2000), pp. 450–452 ( [Kh.S. Shihaliev, S.M. Medvedeva, V.V. Pigarev, A.S. Solov’ev, and G.V. Shatalov. Novye geterociklicheskie soedineniya na osnove 8-R-4,4-dimetil-2,3-ditiolo[5,4-c]hinolin-1-tionov, Zhurnal obshchej himii, 70 (2000), pp. 484-486]).
- S.M. Medvedeva, E.V. Leshcheva, S.S. Kh, and A.S. Solov’ev, Novel heterocyclic systems based on 8-R-4,5-dihydro-4,4-dimethyl[1,2]dithiolo[3,4-c]quinoline-1-thiones, Chem. Heterocycl. Compd. 42 [S.M. Medvedeva, E.V. Leshcheva, Kh.S. Shihaliev, and A.S. Solov’ev. Novye geterociklicheskie sistemy na osnove 8-R-4,5-digidro-4,4-dimetil1,2][3,4-s]hinolin-1-tionov, Himiya geterociklicheskih soedinenij, 14 (2006), pp. 610-615] (2006), pp. 534–539. doi:https://doi.org/10.1007/s10593-006-0122-2.
- R. Vinegar, W. Schreiber, and R. Hugo, Biphasic development of carrageenin edema in rats, J. Pharmacol. Exp. Ther. 166 (1969), pp. 96–103.